Long-term visual outcomes in spasmus nutans

Background The long-term visual outcomes in spasmus nutans patients is largely unknown. The purpose of this study was to characterize visual outcomes and identify comorbid ophthalmic conditions in patients with spasmus nutans. Methods We retrospecti...

Full description

Bibliographic Details
Main Authors: Hennein, Lauren, Heidary, Gena, Gaier, Eric D., Gise, Ryan
Other Authors: Picower Institute for Learning and Memory
Format: Article
Language:English
Published: Springer Science and Business Media LLC 2024
Online Access:https://hdl.handle.net/1721.1/155282
_version_ 1824457939442728960
author Hennein, Lauren
Heidary, Gena
Gaier, Eric D.
Gise, Ryan
author2 Picower Institute for Learning and Memory
author_facet Picower Institute for Learning and Memory
Hennein, Lauren
Heidary, Gena
Gaier, Eric D.
Gise, Ryan
author_sort Hennein, Lauren
collection MIT
description Background The long-term visual outcomes in spasmus nutans patients is largely unknown. The purpose of this study was to characterize visual outcomes and identify comorbid ophthalmic conditions in patients with spasmus nutans. Methods We retrospectively reviewed the charts of consecutive patients diagnosed with spasmus nutans between 2000 and 2020. Demographic information, ophthalmic characteristics, and neuroimaging results were assessed over time. Results Of the 32 patients included in the study, 13 (41%) were female. Underlying medical conditions included a diagnosis of Trisomy 21 in 6 (19%) and prematurity in 8 (25%). Twenty-one patients (66%) self-reported as a race other than Caucasian. 18 patients (56%) had non-private health insurance and 1 (3%) was uninsured. Mean age at diagnosis and resolution were 16 months (range 45 months) and 48 months (range 114 months), respectively. All 32 patients had nystagmus, 31 (97%) had head nodding and 16 (50%) had ocular torticollis. Mean follow-up was 66 months (range 185 months). On initial presentation, 6/32 (19%) had an amblyogenic refractive error and mean best-corrected visual acuity (BCVA) in the better-seeing eye was 0.78 Logarithm of the Minimum Angle of Resolution (LogMAR) (range 1.24). In a sub-analysis that included patients with > 1 exam (n = 23), 17/20 (85%) had an amblyogenic refractive error and mean BCVA in the better-seeing eye was 0.48 LogMAR (range 1.70). At the final exam, 12 patients had measurable stereopsis, eight had strabismus, and three had undergone strabismus surgery. Eight patients required treatment for amblyopia. Conclusions We found a high prevalence of amblyogenic refractive error, strabismus and amblyopia among patients with spasmus nutans. Children with spasmus nutans benefit from ongoing ophthalmic follow-up until they are past the amblyopic age range, even after resolution of nystagmus.
first_indexed 2024-09-23T09:27:43Z
format Article
id mit-1721.1/155282
institution Massachusetts Institute of Technology
language English
last_indexed 2025-02-19T04:17:58Z
publishDate 2024
publisher Springer Science and Business Media LLC
record_format dspace
spelling mit-1721.1/1552822024-12-23T05:43:15Z Long-term visual outcomes in spasmus nutans Hennein, Lauren Heidary, Gena Gaier, Eric D. Gise, Ryan Picower Institute for Learning and Memory Background The long-term visual outcomes in spasmus nutans patients is largely unknown. The purpose of this study was to characterize visual outcomes and identify comorbid ophthalmic conditions in patients with spasmus nutans. Methods We retrospectively reviewed the charts of consecutive patients diagnosed with spasmus nutans between 2000 and 2020. Demographic information, ophthalmic characteristics, and neuroimaging results were assessed over time. Results Of the 32 patients included in the study, 13 (41%) were female. Underlying medical conditions included a diagnosis of Trisomy 21 in 6 (19%) and prematurity in 8 (25%). Twenty-one patients (66%) self-reported as a race other than Caucasian. 18 patients (56%) had non-private health insurance and 1 (3%) was uninsured. Mean age at diagnosis and resolution were 16 months (range 45 months) and 48 months (range 114 months), respectively. All 32 patients had nystagmus, 31 (97%) had head nodding and 16 (50%) had ocular torticollis. Mean follow-up was 66 months (range 185 months). On initial presentation, 6/32 (19%) had an amblyogenic refractive error and mean best-corrected visual acuity (BCVA) in the better-seeing eye was 0.78 Logarithm of the Minimum Angle of Resolution (LogMAR) (range 1.24). In a sub-analysis that included patients with > 1 exam (n = 23), 17/20 (85%) had an amblyogenic refractive error and mean BCVA in the better-seeing eye was 0.48 LogMAR (range 1.70). At the final exam, 12 patients had measurable stereopsis, eight had strabismus, and three had undergone strabismus surgery. Eight patients required treatment for amblyopia. Conclusions We found a high prevalence of amblyogenic refractive error, strabismus and amblyopia among patients with spasmus nutans. Children with spasmus nutans benefit from ongoing ophthalmic follow-up until they are past the amblyopic age range, even after resolution of nystagmus. 2024-06-17T16:43:52Z 2024-06-17T16:43:52Z 2024-06-12 2024-06-16T03:13:13Z Article http://purl.org/eprint/type/JournalArticle 1471-2415 https://hdl.handle.net/1721.1/155282 Hennein, L., Heidary, G., Gaier, E.D. et al. Long-term visual outcomes in spasmus nutans. BMC Ophthalmol 24, 253 (2024). PUBLISHER_CC en 10.1186/s12886-024-03494-7 BMC Ophthalmology Creative Commons Attribution https://creativecommons.org/licenses/by/4.0/ The Author(s) application/pdf Springer Science and Business Media LLC BioMed Central
spellingShingle Hennein, Lauren
Heidary, Gena
Gaier, Eric D.
Gise, Ryan
Long-term visual outcomes in spasmus nutans
title Long-term visual outcomes in spasmus nutans
title_full Long-term visual outcomes in spasmus nutans
title_fullStr Long-term visual outcomes in spasmus nutans
title_full_unstemmed Long-term visual outcomes in spasmus nutans
title_short Long-term visual outcomes in spasmus nutans
title_sort long term visual outcomes in spasmus nutans
url https://hdl.handle.net/1721.1/155282
work_keys_str_mv AT henneinlauren longtermvisualoutcomesinspasmusnutans
AT heidarygena longtermvisualoutcomesinspasmusnutans
AT gaierericd longtermvisualoutcomesinspasmusnutans
AT giseryan longtermvisualoutcomesinspasmusnutans